MGP Ingredients Q2 2024 Adj. EPS $1.71 Beats $1.54 Estimate, Sales $190.805M Beat $189.056M Estimate
Portfolio Pulse from Benzinga Newsdesk
MGP Ingredients (NASDAQ:MGPI) reported Q2 2024 adjusted EPS of $1.71, beating the estimate of $1.54. Sales were $190.805M, surpassing the $189.056M estimate but down 8.71% from last year's $209.001M.
August 01, 2024 | 11:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MGP Ingredients reported better-than-expected Q2 2024 earnings and sales, with EPS of $1.71 beating estimates by 11.04% and sales of $190.805M surpassing estimates by 0.93%. However, sales were down 8.71% year-over-year.
The better-than-expected EPS and sales figures are likely to have a positive short-term impact on MGPI's stock price. However, the year-over-year decline in sales may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100